Novo Nordisk As operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Novo Nordisk As with three other
companies in this sector in the United States:
sales of $20.85 billion
of which 33%
Bristol-Myers Squibb Company
of which 100%
was Pharmaceuticals), and
of which 41%
was US Medical Aesthetics).
During the year ended December of 2016, sales at
Novo Nordisk As were $16.58 billion.
increase of 3.9%
versus 2015, when the company's sales were $15.96 billion.
This was the fifth consecutive year of sales increases at Novo Nordisk As
(and since 2011, sales have increased a total of 33%).
Sales of Diabetes Care saw an increase
4.2% in 2016, from
$12.66 billion to $13.19 billion.